Daily Sugary Drinks Were Tied to a Higher Gastric Cancer Risk
A common habit now sits under sharper scrutiny. In a decades-long analysis of more than 112,000 U.S. adults, people who drank at least one sugar-sweetened beverage each day had a markedly higher risk of gastric cancer than those who rarely consumed these drinks. The association was seen in both women and men, and it persisted after adjustment for other factors that could influence cancer risk.
The signal was not subtle. Daily consumption of sugary drinks was associated with a 2.45-fold higher risk of gastric cancer compared with intake of less than one serving per month. Among women in the Nurses’ Health Study, more than one sugary drink per day was linked to a 3.04-fold higher risk versus very rare consumption. Artificially sweetened beverages did not show a similar association after adjustment.
A Large Cohort, but a Small Number of Cancers
The analysis drew on two major prospective cohorts: the Nurses’ Health Study and the Health Professionals Follow-Up Study. Together they included 112,284 participants whose diet, lifestyle, and medical history were tracked over many years. During follow-up, 278 participants developed gastric cancer.
Those numbers matter for interpretation. The cohort was large and the exposure data were collected prospectively, which strengthens the analysis, but gastric cancer itself remained uncommon in the population studied. Even so, the observed difference between very low and very high sugary beverage intake was large enough to raise a serious epidemiologic concern.
The beverage category included carbonated soft drinks, punch, lemonade, and sports drinks. Artificially sweetened beverages were defined as low-calorie carbonated drinks. Higher overall fructose intake tracked with a greater incidence of gastric cancer as well, which fits with the idea that the biological burden may relate to the sugar load rather than the carbonation or the beverage form alone.
Why Fructose Exposure May Matter in the Upper Gastrointestinal Tract
The finding invites mechanistic questions that go beyond a simple calorie count. Fructose-rich beverages can drive metabolic stress, alter insulin signaling, and contribute to systemic inflammation. In the stomach, repeated exposure to a high-sugar dietary pattern may also influence the local environment through effects on body weight, glucose homeostasis, and the gut microbiome, all of which can shape carcinogenic pathways over time.
This does not prove causation, and it should not be treated as a direct biologic verdict on soda. Still, the pattern is plausible enough to justify closer study. Cancer risk often emerges from repeated low-grade exposures that interact with host susceptibility, and beverage intake is one of the few dietary variables people repeat daily for years.
The H. pylori Question Did Not Explain the Pattern
Because Helicobacter pylori infection is a well-established gastric cancer risk factor, the investigators also examined whether it could account for the association. H. pylori status was available for a subset of 940 participants, and just over one third showed evidence of infection. No association emerged between sugary beverage consumption and H. pylori infection.
That finding narrows one possible explanation without eliminating the broader association. If sugary beverage intake were simply a marker for higher H. pylori prevalence, the pattern might have collapsed in subgroup analysis. Instead, the beverage signal remained separate from the infection data available here, which suggests another pathway may be operating, or that sugary drink intake is capturing an unmeasured combination of dietary and lifestyle risks.
Artificial Sweeteners Looked Different in This Dataset
The contrast with diet drinks was striking. Greater consumption of artificially sweetened beverages was not associated with higher gastric cancer incidence after accounting for other potential factors. In practical terms, this does not establish that diet drinks are protective or biologically neutral in all settings. It does indicate that the signal in this study was specific to sugar-sweetened beverages rather than to sweetened drinks as a broad category.
That distinction may reflect different metabolic effects. Sugar-sweetened beverages deliver a rapid glycemic and fructose burden, while low-calorie beverages do not impose the same sugar exposure. If the relevant pathway involves metabolic inflammation, insulin resistance, or downstream changes in adiposity and tissue repair, the divergence between the two drink types becomes easier to understand.
Observational Data Can Point, Not Prove
The study remains observational, so it cannot establish that sugary drinks cause gastric cancer. Residual confounding is still possible. People who regularly consume these beverages may differ in other ways that are difficult to measure completely, including broader dietary habits, health behaviors, and family history.
Two limitations deserve particular attention. First, information on H. pylori status and family history was limited. Second, the study population was predominantly white, which makes it difficult to know whether the same association would look the same across racial and ethnic groups. Those gaps do not erase the finding, but they do set the boundaries of what can be claimed.
What Clinicians and Patients Should Take From the Data
For now, the most defensible reading is straightforward: daily sugar-sweetened beverage intake was linked with higher gastric cancer incidence in a large U.S. cohort, while artificially sweetened drinks were not. The pattern was strong enough to merit attention, especially because sugary beverage intake is common and modifiable.
The bedside implication is not to turn a single beverage into a cancer diagnosis, but to treat repeated sugary drink intake as part of a broader carcinogenic diet pattern worth discussing in preventive care. Patients with other gastric cancer risks may deserve especially firm counseling about limiting sugar-sweetened beverages.
Further research will need to determine whether the association holds in more diverse populations and whether mechanistic work can identify the pathway linking sugary drinks to gastric malignancy. Until then, this study adds a new entry to the list of cancers associated with high intake of sugar-sweetened beverages, and it does so with enough consistency to keep the question in view.